{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:10:09Z","timestamp":1784196609159,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bladder metastasis from gastric cancer is extremely rare and may be misdiagnosed, particularly during immunotherapy, when new urinary symptoms can be attributed to genitourinary immune-related adverse events. We report a case of a 35-year-old man with advanced gastric cancer who initially responded to chemotherapy combined with sintilimab, an anti\u2013Programmed Death-1 (PD-1) inhibitor. After four cycles, he developed acute kidney injury and progressive obstructive uropathy, including bilateral hydronephrosis and diffuse irregular bladder wall thickening, whereas the primary gastric lesion remained stable. Routine urinalysis revealed no such abnormalities. Cystoscopy revealed patchy follicular mucosal elevations with non-visualization of both ureteral orifices. Ureteral stent placement failed, and bilateral percutaneous nephrostomy was performed, resulting in partial recovery of the renal function. Bladder biopsy confirmed a metastatic poorly differentiated adenocarcinoma with signet-ring cell features. Immunohistochemistry was positive for caudal-type homeobox 2 (CDX2), cytokeratin 20 (CK20) and Villin, consistent with gastric origin. Despite urinary diversion, the disease progressed rapidly, leading to multiple organ failure and death in the patient. This case highlights the importance of early cystoscopy and targeted biopsy in patients receiving immunotherapy who develop new urinary symptoms or atypical urinary tract imaging findings to distinguish metastatic disease from immunotherapy-related toxicity.<\/jats:p>","DOI":"10.3389\/fonc.2026.1848708","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:25:48Z","timestamp":1782793548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiaojiao","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1365-2559.2000.00797.x","article-title":"Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases","volume":"36","author":"Bates","year":"2000","journal-title":"Histopathology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8848841","article-title":"Unusual bladder metastasis from a primary gastric carcinoma: two case reports and review of literature","volume":"2020","author":"Nouioui","year":"2020","journal-title":"Case Rep Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2020.100688","article-title":"Hyperprogressive disease in patients receiving immune checkpoint inhibitors","volume":"45","author":"Zhang","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051577","article-title":"Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: case report and literature review","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1501415","article-title":"Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis\/cystitis treated by ureteral stent and review of the literature","volume":"15","author":"Ji","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-08-2457","article-title":"E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man","volume":"69","author":"Humar","year":"2009","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/s0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/jci39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70034","article-title":"N(6)-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis","volume":"45","author":"Li","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112039","article-title":"Gastric cancer-derived exosomal miR-196a-5p remodels the pre-metastatic niche for peritoneal dissemination","volume":"135","author":"Zhang","year":"2025","journal-title":"Cell Signal"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652378","article-title":"Exosomes promote pre-metastatic niche formation in gastric cancer","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00240-6","article-title":"Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities","volume":"2","author":"Tanaka","year":"2021","journal-title":"Nat Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01948-6","article-title":"The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA-RNA interactions and drives gastric cancer metastasis via miR-138-5p\/ITGA2 axis","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2010.14.2.130","article-title":"A case of bladder cancer found during a workup for urge incontinence","volume":"14","author":"Song","year":"2010","journal-title":"Int Neurourol J"},{"key":"B20","article-title":"Bladder metastasis of signet-ring cell adenocarcinoma from the stomach","volume":"53","author":"Valero Puerta","year":"2000","journal-title":"Arch Esp Urol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"Fso912","DOI":"10.2144\/fsoa-2023-0127","article-title":"Bladder metastasis originating from gastric signet-ring cell carcinoma: a case report","volume":"10","author":"Moalla","year":"2024","journal-title":"Future Sci OA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1752-1947-7-204","article-title":"Occurrence of bladder metastasis 10 years after surgical removal of a primary gastric cancer: a case report and review of the literature","volume":"7","author":"Andr\u00e1s","year":"2013","journal-title":"J Med Case Rep"},{"key":"B23","article-title":"Secondary adenocarcinoma of the urinary bladder from a primary gastric cancer","volume":"55","author":"Farhat","year":"2007","journal-title":"J Med Liban"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123413","article-title":"A case report of immunotherapy-resistant MSI-H gastric cancer with significant intrapatient tumoral heterogeneity characterized by histologic dedifferentiation","volume":"11","author":"Kethireddy","year":"2022","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001253","article-title":"Intratumoral immune response to gastric cancer varies by molecular and histologic subtype","volume":"43","author":"Kim","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.4436","article-title":"De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry","volume":"235","author":"Balluff","year":"2015","journal-title":"J Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002435","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/cji.0000000000000581","article-title":"Immune checkpoint inhibitor-induced ureteritis and cystitis in patients with lung cancer and uterine Malignancies: a case series and literature review","volume":"49","author":"Yan","year":"2026","journal-title":"J Immunother"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000765","article-title":"Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma","volume":"31","author":"Schneider","year":"2021","journal-title":"Melanoma Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02222-w","article-title":"Imaging findings of infectious and inflammatory diseases of the urinary system mimicking neoplastic diseases","volume":"45","author":"Karaosmanoglu","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7326\/aitc202402200","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-011-5482-6_56","article-title":"Obstructive nephropathy","volume":"39","author":"Klahr","year":"2000","journal-title":"Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae035","article-title":"Management of Malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy","volume":"111","author":"Blackmur","year":"2024","journal-title":"Br J Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112354","article-title":"Outcomes related to percutaneous nephrostomies (PCN) in Malignancy-associated ureteric obstruction: a systematic review of the literature","volume":"10","author":"New","year":"2021","journal-title":"J Clin Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1848708\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:50:22Z","timestamp":1784195422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1848708\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":37,"alternative-id":["10.3389\/fonc.2026.1848708"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1848708","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1848708"}}